228 filings
Page 8 of 12
8-K
urou b2ylk3
20 May 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
gokuye q1r8
6 May 11
Rigel Assumes Development Responsibility for Inhaled Asthma Therapy
12:00am
8-K
8xvjw9xghvc
3 May 11
Rigel Announces First Quarter Financial Results
12:00am
8-K
msyzs37 hti
1 Mar 11
Rigel Announces Fourth Quarter and Year End 2010 Financial Results
12:00am
8-K
khe9fdsu0lplk8g
9 Feb 11
Departure of Directors or Certain Officers
12:00am
8-K
1ahs bktf0awg5p
17 Dec 10
Departure of Directors or Certain Officers
12:00am
8-K
n3g p70ea1u79
2 Nov 10
Rigel Announces Third Quarter 2010 Financial Results
12:00am
8-K
jrgxth 6ist0mq
3 Aug 10
Rigel Announces Second Quarter 2010 Financial Results
12:00am
8-K
niloyjjk3w4 fk9
1 Jun 10
Rigel Pharmaceuticals Names Raul Rodriguez President
12:00am
8-K
dz5umvgj imebao0y8ry
4 May 10
Rigel Announces First Quarter 2010 Financial Results
12:00am
8-K
rctehz2k68gs 7ch1vu1
2 Mar 10
Rigel Announces Fourth Quarter and Year End 2009 Financial Results
12:00am
8-K
ogjsiahx18ir8jgem
18 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
vp96ud 9yayjna
3 Nov 09
Rigel Announces Third Quarter 2009 Financial Results
12:00am
8-K/A
wzxblxl0lavj vv9r
18 Sep 09
Financial Statements and Exhibits
12:00am
8-K
7rkr5o7g23ijcsym
17 Sep 09
Other Events
12:00am
8-K
nawki6n
4 Aug 09
Rigel Announces Second Quarter 2009 Financial Results
12:00am
8-K
9n8kefgf
24 Jul 09
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies — Results Incongruent
12:00am
8-K
igw vm5pdyzqhstr1
9 Jul 09
Rigel’s R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
12:00am
8-K
9z2o4
5 May 09
Rigel Announces First Quarter 2009 Financial Results
12:00am
8-K
nowvemfuwpsgz yrx65e
1 Apr 09
Departure of Directors or Certain Officers
12:00am